Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China · Delayed Price · Currency is CNY 11.40
+0.14 (1.24%)
Last updated: Nov 3, 2025, 9:42 AM CST
SHE:301301 Revenue
Yili Chuanning Biotechnology had revenue of 1.09B CNY in the quarter ending September 30, 2025, a decrease of -13.76%. This brings the company's revenue in the last twelve months to 4.74B, down -16.85% year-over-year. In the year 2024, Yili Chuanning Biotechnology had annual revenue of 5.76B with 19.38% growth.
Revenue (ttm)
4.74B
Revenue Growth
-16.85%
P/S Ratio
5.36
Revenue / Employee
1.49M
Employees
3,184
Market Cap
25.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.76B | 934.97M | 19.38% |
| Dec 31, 2023 | 4.82B | 1.00B | 26.24% |
| Jan 1, 2023 | 3.82B | 588.64M | 18.21% |
| Jan 1, 2022 | 3.23B | -417.40M | -11.44% |
| Dec 31, 2020 | 3.65B | 505.98M | 16.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 43.09B |
| WuXi AppTec | 43.07B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Medicine | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |